Stock Events

Stock Events

Sandoz Group 

€0
0
-€71.98-100% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25FebExpected
Q4 2025
1.55
1.6
1.66
1.71
Expected EPS
1.54616401548
Actual EPS
1.714041

People Also Follow

This list is based on the watchlists of people on Stock Events who follow D8Y.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries is a leading global pharmaceutical company that produces generic and specialty medicines, directly competing with Sandoz in the generics market.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie operates in the pharmaceuticals sector focusing on branded drug development, competing with Sandoz's biosimilars and generic pharmaceuticals.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a research-based biopharmaceutical company that competes with Sandoz in the development and marketing of generic and biosimilar drugs.
Novartis
NVS
Mkt Cap297.32B
Novartis, the parent company of Sandoz, competes in the pharmaceutical industry but is listed separately due to its broader portfolio of patented drugs, which indirectly competes with Sandoz's generics and biosimilars.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson is a comprehensive healthcare company that produces a wide range of pharmaceutical products, competing with Sandoz in various therapeutic areas.
Merck
MRK
Mkt Cap298.84B
Merck & Co. is a global healthcare company that produces prescription medicines, vaccines, biologic therapies, and animal health products, competing with Sandoz in the pharmaceutical sector.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that researches and develops a wide range of pharmaceutical products, competing with Sandoz in the generics and biosimilars market.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global biopharmaceutical company focused on human health, competing with Sandoz in the areas of generic drugs and biosimilars.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Sandoz in developing and marketing biosimilar products and in the generics field.

About

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Show more...
CEO
Mr. Richard Saynor
Employees
22356
Country
United Kingdom
ISIN
CH1243598427

Listings

F
DE
D8Y.F
LSE
GB
0SAN.LSE
STU
DE
D8Y0.STU
MU
DE
D8Y.MU

0 Comments

Share your thoughts

FAQ

What is Sandoz Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sandoz Group stocks are traded under the ticker D8Y.MU.
When is the next Sandoz Group earnings date?▼
Sandoz Group is going to release the next earnings report on August 05, 2026.
What were Sandoz Group earnings last quarter?▼
D8Y.MU earnings for the last quarter are 1.71 EUR per share, whereas the estimation was 1.55 EUR resulting in a +10.86% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Sandoz Group have?▼
As of April 12, 2026, the company has 22,356 employees.
In which sector is Sandoz Group located?▼
Sandoz Group operates in the Other sector.
When did Sandoz Group complete a stock split?▼
Sandoz Group has not had any recent stock splits.
Where is Sandoz Group headquartered?▼
Sandoz Group is headquartered in Basel, United Kingdom.